Viewing Study NCT05726032


Ignite Creation Date: 2025-12-24 @ 10:02 PM
Ignite Modification Date: 2025-12-25 @ 7:38 PM
Study NCT ID: NCT05726032
Status: RECRUITING
Last Update Posted: 2025-10-07
First Post: 2023-02-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Empagliflozin in Patients With Cirrhosis and Ascites
Sponsor: Yale University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-09-11
Start Date Type: ACTUAL
Primary Completion Date: 2025-12-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-12-01
Completion Date Type: ESTIMATED
First Submit Date: 2023-02-02
First Submit QC Date: None
Study First Post Date: 2023-02-13
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-10-06
Last Update Post Date: 2025-10-07
Last Update Post Date Type: ESTIMATED